Nonalcoholic fatty liver disease (NAFLD) is a main hepatic manifestation of metabolic
syndrome. It represents a wide spectrum of histopathological abnormalities ranging from …

strongly with insulin resistance. Excess upper body fat can accumulate either
intraperitoneally (visceral fat) or subcutaneously. Many investigators claim that excess …

Non-alcoholic fatty liver disease is a serious and growing clinical problem. Despite lifestyle
modification, ie diet and physical activity, being the recommended therapy, there are …

Nonalcoholic fatty liver disease (NAFLD) refers to a spectrum of liver damage ranging from
simple steatosis to nonalcoholic steatohepatitis (NASH), advanced fibrosis and cirrhosis …

Background Non‐alcoholic fatty liver disease (NAFLD) patients with elevated serum alanine
aminotransferase (ALT) generally undergo a liver biopsy to evaluate for possible non …

Insulin resistance is a key feature of the metabolic syndrome and often progresses to type 2
diabetes. Both insulin resistance and type 2 diabetes are characterized by dyslipidemia …

Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized cause of liver
disease in the United States and worldwide. With obesity being an important risk factor …

It is uncertain whether patients with nonalcoholic fatty liver disease (NAFLD) and normal
alanine aminotransferase (ALT) have a milder disease and should undergo liver biopsy. We …

Background Non‐alcoholic fatty liver disease (NAFLD) is a highly prevalent condition.
Emerging evidence suggests that vitamin D may play a role in the pathogenesis of NAFLD …

Nonalcoholic fatty liver disease (NAFLD) has been recognized as a major health burden.
The high prevalence of NAFLD is probably due to the contemporary epidemics of obesity …